Medication info
Hyundai Tibolone Tablet 2.5 mg

Hyundai Tibolone Tablet 2.5 mg

Prescription medicationTablet경구
Ingredient · strength
Tibolone›2.5mg / 1 tablet
Manufacturer / importer
현대약품(주)
Appearance
White oblong tablets
Packaging
28 tablets (28 tablets/PTP X 1)
Approval status
Active

MFDS item code 201900782 · Approved 2019.01.31 · Insurance code 642004280

Summary

Main use
Improvement of estrogen deficiency symptoms and prevention of osteoporosis
Who takes it
Adults
Adult dose
Take one tablet of this medication daily at the same time each day. The tablet is recommended to be taken with water or other beverages, and adherence to the same time daily is advised. If a dose is missed, take it immediately within 12 hours. If more than 12 hours have passed, do not take the missed dose, and continue with the next normal dosing schedule.

Ingredients

Manufacturer
현대약품(주)

Efficacy & effects

Improvement of estrogen deficiency symptoms and prevention of osteoporosis

  • Symptoms of estrogen deficiency
  • osteoporosis
View approved original text

This medication helps relieve symptoms caused by estrogen deficiency in women who have gone through menopause for more than one year. It is also used to prevent osteoporosis in postmenopausal women at high risk of fractures when other osteoporosis prevention medicines cannot be used or are not tolerated.

How to take

Adult dose

Take one tablet of this medication daily at the same time each day. The tablet is recommended to be taken with water or other beverages, and adherence to the same time daily is advised. If a dose is missed, take it immediately within 12 hours. If more than 12 hours have passed, do not take the missed dose, and continue with the next normal dosing schedule.

Precautions

This medication should not be administered to pregnant or breastfeeding women. It should not be used in patients with or suspected of having breast cancer, or those with a history of breast cancer. Patients with or suspected of having estrogen-dependent malignancies, such as endometrial carcinoma, should also not take this medication. Patients with unexplained vaginal bleeding or untreated endometrial hyperplasia should not take this medication. It is contraindicated in patients with a history of venous thromboembolism or those with conditions that increase the risk of thrombosis, and in patients with a history of arterial thromboembolism. Patients with severely impaired liver function and those with hypersensitivity to the components of this medication should also not take it. It should not be administered in cases of genetic lactose intolerance. The medication should be stopped if specific symptoms occur; for example, jaundice or worsening of liver function, elevation of blood pressure, or headaches like migraines require immediate discontinuation. Patients with uterine fibroids, endometriosis, risk factors for thromboembolism, hypertension, liver disease, diabetes, migraines, systemic lupus erythematosus, a history of endometrial hyperplasia, epilepsy, asthma, and otosclerosis require special caution while taking this medication. During treatment with this medication, various adverse reactions such as lower abdominal pain, abnormal hair growth, acne, increased vaginal discharge, increased endometrial thickness, postmenopausal bleeding, breast tenderness, genital itching, vaginal candidiasis, pelvic pain, cervical dysplasia may occur. Also reported are symptoms such as weight gain, dizziness, rash, headache, depression, edema, myalgia, and abnormal liver function. This medication may increase the risk of serious conditions such as breast cancer, endometrial cancer, ischemic stroke, ovarian cancer, venous thromboembolism, coronary artery disease, necessitating careful evaluation of the patient’s condition before and during use, along with regular check-ups. Women over 60 years old should be especially cautious as the risk of stroke is heightened. This medication can enhance the effects of anticoagulants when used together, therefore patients taking medications like warfarin may require dose adjustments. Additionally, using this medication in combination with drugs that induce specific liver enzymes may reduce its effectiveness, hence it is essential to consult a physician or pharmacist about any concurrent medications. It should not be taken during pregnancy, and if pregnancy is confirmed while taking the medication, it should be discontinued immediately. Breastfeeding women should also not use this medication. In case of overdose, symptoms like nausea, vomiting, and vaginal bleeding may occur, and appropriate medical treatment should be sought immediately if these symptoms manifest. This medication should be kept out of reach of children and stored in its original packaging to maintain its effectiveness. It must not be used for contraceptive purposes, and regular check-ups and strict adherence to the physician's instructions are essential for therapeutic effectiveness and safety.

Side effects and when to seek care immediately

Serious side effects

Headache (including migraine-type), edema, elevated blood pressure, abnormal liver function (jaundice), skin rash, severe allergic reactions, stroke (including ischemic stroke), venous thromboembolism, myocardial infarction, difficulty breathing, symptoms of thromboembolism (painful leg swelling, sudden chest pain, shortness of breath)

Mild side effects

  • Lower abdominal pain
  • abnormal hair growth
  • acne
  • vaginal discharge
  • increased endometrial thickness
  • postmenopausal bleeding
  • breast tenderness
  • genital itching
  • vaginal candidiasis
  • vaginal bleeding
Show 17 more
  • pelvic pain
  • cervical dysplasia
  • genital discharge
  • vulvovaginal candidiasis
  • breast discomfort
  • fungal infections
  • vaginitis
  • nipple pain
  • weight gain
  • abnormal cervical cytology
  • dizziness
  • rash
  • pruritus
  • seborrheic dermatitis
  • headache
  • migraine
  • visual disturbances

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and moisture, so it should be stored in a tightly sealed container. Additionally, it is advisable to keep it in a cool room at or below 25 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

White oblong tablets

Package unit

28 tablets (28 tablets/PTP X 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.